1 | search | 14,902 |
2 | double-step | 12 |
3 | test-and-treat | 9 |
4 | meta-review | 7 |
5 | koufuye | 5 |
6 | cross-product | 4 |
7 | dsme/s | 4 |
8 | sobane | 4 |
9 | chemotherapy-first | 3 |
10 | decrease/increase | 3 |
11 | feature-attribute-matching-plus-user-feedback | 3 |
12 | handgrips | 3 |
13 | interventionalist-transfer | 3 |
14 | spaniel | 3 |
15 | 'search | 2 |
16 | 9/2-pcr | 2 |
17 | bias-reduction | 2 |
18 | coach2move | 2 |
19 | coimmunization | 2 |
20 | cyclosporine-sparing | 2 |
21 | endovascular-first | 2 |
22 | literature-searching | 2 |
23 | log10rdr | 2 |
24 | patient-transfer | 2 |
25 | tcd-directed | 2 |
26 | trial-like | 2 |
27 | underpayment | 2 |
28 | ¹³carbon | 2 |
29 | 'carbon-fixing | 1 |
30 | 'expectancy-value | 1 |
31 | 'icd | 1 |
32 | 1,1-diarylprop-2-yn-1-ol | 1 |
33 | 12-multidrug-resistant | 1 |
34 | 13,124 | 1 |
35 | 143,600 | 1 |
36 | 3-hole-2-particle | 1 |
37 | 8,746 | 1 |
38 | alpha-adaptive | 1 |
39 | assacharolytic | 1 |
40 | atenolol-hydrochlorothiazide-based | 1 |
41 | auto-excision | 1 |
42 | brand/slang | 1 |
43 | brca-testing | 1 |
44 | carboxycelluloses | 1 |
45 | claw-like | 1 |
46 | coindexing | 1 |
47 | compression-ignition | 1 |
48 | delayed-operation | 1 |
49 | diagnostic-treatment | 1 |
50 | dihydroxy-imidazolidine | 1 |
51 | dose-individualization | 1 |
52 | dose-to-rash | 1 |
53 | e-guidance | 1 |
54 | ed-saving | 1 |
55 | efficiency-in | 1 |
56 | empiric-and-laboratory | 1 |
57 | halo-capping | 1 |
58 | health-themed | 1 |
59 | hub-and-spoke | 1 |
60 | hunger-score | 1 |
61 | microcarpus | 1 |
62 | multiply-mapped | 1 |
63 | nicotine-reducing | 1 |
64 | over-payment | 1 |
65 | pdufa | 1 |
66 | ph=5 | 1 |
67 | pharmaco-ablative | 1 |
68 | phospholipid-assisted | 1 |
69 | play-the-winner-and-drop-the-loser | 1 |
70 | pointone | 1 |
71 | protease-inhibitor-switch | 1 |
72 | pulay | 1 |
73 | qcar-based | 1 |
74 | reviewobjectives | 1 |
75 | rsik | 1 |
76 | rule-in/rule-out | 1 |
77 | scaffold-hopping | 1 |
78 | search/review | 1 |
79 | seven-level | 1 |
80 | sfigmopletizmografiyu | 1 |
81 | significant-imbalance | 1 |
82 | single-fem-compensation | 1 |
83 | slow-taper | 1 |
84 | still-debatable | 1 |
85 | subclavian/internal | 1 |
86 | thatthere | 1 |
87 | thoracolysis | 1 |
88 | trajectory-analyses | 1 |
89 | transplantation.lymphedema | 1 |
90 | verapamil-trandolapril-based | 1 |
91 | vl-based | 1 |
92 | warts.there | 1 |
93 | weblink | 1 |
94 | years.fascial | 1 |
1 | 'carbon-fixing | 1 |
2 | 'expectancy-value | 1 |
3 | 'icd | 1 |
4 | 'search | 2 |
5 | 1,1-diarylprop-2-yn-1-ol | 1 |
6 | 12-multidrug-resistant | 1 |
7 | 13,124 | 1 |
8 | 143,600 | 1 |
9 | 3-hole-2-particle | 1 |
10 | 8,746 | 1 |
11 | 9/2-pcr | 2 |
12 | alpha-adaptive | 1 |
13 | assacharolytic | 1 |
14 | atenolol-hydrochlorothiazide-based | 1 |
15 | auto-excision | 1 |
16 | bias-reduction | 2 |
17 | brand/slang | 1 |
18 | brca-testing | 1 |
19 | carboxycelluloses | 1 |
20 | chemotherapy-first | 3 |
21 | claw-like | 1 |
22 | coach2move | 2 |
23 | coimmunization | 2 |
24 | coindexing | 1 |
25 | compression-ignition | 1 |
26 | cross-product | 4 |
27 | cyclosporine-sparing | 2 |
28 | decrease/increase | 3 |
29 | delayed-operation | 1 |
30 | diagnostic-treatment | 1 |
31 | dihydroxy-imidazolidine | 1 |
32 | dose-individualization | 1 |
33 | dose-to-rash | 1 |
34 | double-step | 12 |
35 | dsme/s | 4 |
36 | e-guidance | 1 |
37 | ed-saving | 1 |
38 | efficiency-in | 1 |
39 | empiric-and-laboratory | 1 |
40 | endovascular-first | 2 |
41 | feature-attribute-matching-plus-user-feedback | 3 |
42 | halo-capping | 1 |
43 | handgrips | 3 |
44 | health-themed | 1 |
45 | hub-and-spoke | 1 |
46 | hunger-score | 1 |
47 | interventionalist-transfer | 3 |
48 | koufuye | 5 |
49 | literature-searching | 2 |
50 | log10rdr | 2 |
51 | meta-review | 7 |
52 | microcarpus | 1 |
53 | multiply-mapped | 1 |
54 | nicotine-reducing | 1 |
55 | over-payment | 1 |
56 | patient-transfer | 2 |
57 | pdufa | 1 |
58 | ph=5 | 1 |
59 | pharmaco-ablative | 1 |
60 | phospholipid-assisted | 1 |
61 | play-the-winner-and-drop-the-loser | 1 |
62 | pointone | 1 |
63 | protease-inhibitor-switch | 1 |
64 | pulay | 1 |
65 | qcar-based | 1 |
66 | reviewobjectives | 1 |
67 | rsik | 1 |
68 | rule-in/rule-out | 1 |
69 | scaffold-hopping | 1 |
70 | search | 14,902 |
71 | search/review | 1 |
72 | seven-level | 1 |
73 | sfigmopletizmografiyu | 1 |
74 | significant-imbalance | 1 |
75 | single-fem-compensation | 1 |
76 | slow-taper | 1 |
77 | sobane | 4 |
78 | spaniel | 3 |
79 | still-debatable | 1 |
80 | subclavian/internal | 1 |
81 | tcd-directed | 2 |
82 | test-and-treat | 9 |
83 | thatthere | 1 |
84 | thoracolysis | 1 |
85 | trajectory-analyses | 1 |
86 | transplantation.lymphedema | 1 |
87 | trial-like | 2 |
88 | underpayment | 2 |
89 | verapamil-trandolapril-based | 1 |
90 | vl-based | 1 |
91 | warts.there | 1 |
92 | weblink | 1 |
93 | years.fascial | 1 |
94 | ¹³carbon | 2 |
1 | 143,600 | 1 |
2 | 13,124 | 1 |
3 | ph=5 | 1 |
4 | 8,746 | 1 |
5 | pdufa | 1 |
6 | transplantation.lymphedema | 1 |
7 | assacharolytic | 1 |
8 | 'icd | 1 |
9 | health-themed | 1 |
10 | multiply-mapped | 1 |
11 | atenolol-hydrochlorothiazide-based | 1 |
12 | verapamil-trandolapril-based | 1 |
13 | vl-based | 1 |
14 | qcar-based | 1 |
15 | tcd-directed | 2 |
16 | phospholipid-assisted | 1 |
17 | e-guidance | 1 |
18 | significant-imbalance | 1 |
19 | trial-like | 2 |
20 | claw-like | 1 |
21 | hub-and-spoke | 1 |
22 | still-debatable | 1 |
23 | 3-hole-2-particle | 1 |
24 | sobane | 4 |
25 | dihydroxy-imidazolidine | 1 |
26 | pointone | 1 |
27 | warts.there | 1 |
28 | thatthere | 1 |
29 | hunger-score | 1 |
30 | decrease/increase | 3 |
31 | 'expectancy-value | 1 |
32 | pharmaco-ablative | 1 |
33 | alpha-adaptive | 1 |
34 | coach2move | 2 |
35 | koufuye | 5 |
36 | brand/slang | 1 |
37 | nicotine-reducing | 1 |
38 | literature-searching | 2 |
39 | halo-capping | 1 |
40 | scaffold-hopping | 1 |
41 | cyclosporine-sparing | 2 |
42 | brca-testing | 1 |
43 | ed-saving | 1 |
44 | coindexing | 1 |
45 | 'carbon-fixing | 1 |
46 | search | 14,902 |
47 | 'search | 2 |
48 | protease-inhibitor-switch | 1 |
49 | dose-to-rash | 1 |
50 | feature-attribute-matching-plus-user-feedback | 3 |
51 | rsik | 1 |
52 | weblink | 1 |
53 | years.fascial | 1 |
54 | subclavian/internal | 1 |
55 | spaniel | 3 |
56 | seven-level | 1 |
57 | 1,1-diarylprop-2-yn-1-ol | 1 |
58 | efficiency-in | 1 |
59 | ¹³carbon | 2 |
60 | auto-excision | 1 |
61 | delayed-operation | 1 |
62 | single-fem-compensation | 1 |
63 | dose-individualization | 1 |
64 | coimmunization | 2 |
65 | bias-reduction | 2 |
66 | compression-ignition | 1 |
67 | double-step | 12 |
68 | 9/2-pcr | 2 |
69 | log10rdr | 2 |
70 | patient-transfer | 2 |
71 | interventionalist-transfer | 3 |
72 | slow-taper | 1 |
73 | play-the-winner-and-drop-the-loser | 1 |
74 | dsme/s | 4 |
75 | carboxycelluloses | 1 |
76 | trajectory-analyses | 1 |
77 | reviewobjectives | 1 |
78 | thoracolysis | 1 |
79 | handgrips | 3 |
80 | microcarpus | 1 |
81 | test-and-treat | 9 |
82 | cross-product | 4 |
83 | 12-multidrug-resistant | 1 |
84 | diagnostic-treatment | 1 |
85 | over-payment | 1 |
86 | underpayment | 2 |
87 | endovascular-first | 2 |
88 | chemotherapy-first | 3 |
89 | rule-in/rule-out | 1 |
90 | sfigmopletizmografiyu | 1 |
91 | meta-review | 7 |
92 | search/review | 1 |
93 | pulay | 1 |
94 | empiric-and-laboratory | 1 |